Pekin Hardy Strauss’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Sell |
2,655
-500
| -16% | -$41.5K | 0.03% | 332 |
|
|
2025
Q1 | $256K | Hold |
3,155
| – | – | 0.03% | 303 |
|
|
2024
Q4 | $284K | Buy |
3,155
+675
| +27% | +$60.8K | 0.04% | 301 |
|
|
2024
Q3 | $245K | Hold |
2,480
| – | – | 0.03% | 301 |
|
|
2024
Q2 | $230K | Buy |
2,480
+225
| +10% | +$20.9K | 0.03% | 290 |
|
|
2024
Q1 | $214K | Buy |
+2,255
| New | +$214K | 0.03% | 298 |
|
|
2023
Q2 | – | Sell |
-8,688
| Closed | -$662K | – | 329 |
|
|
2023
Q1 | $662K | Sell |
8,688
-5,840
| -40% | -$445K | 0.09% | 178 |
|
|
2022
Q4 | $1.21M | Sell |
14,528
-2,295
| -14% | -$190K | 0.17% | 124 |
|
|
2022
Q3 | $1.33M | Sell |
16,823
-4,725
| -22% | -$375K | 0.21% | 111 |
|
|
2022
Q2 | $1.6M | Buy |
21,548
+16,880
| +362% | +$1.25M | 0.23% | 105 |
|
|
2022
Q1 | $420K | Buy |
+4,668
| New | +$420K | 0.05% | 237 |
|